AAAAAA

   
Results: 1-20 |
Results: 20
QS-21 promotes an adjuvant effect allowing for reduced antigen dose duringHIV-1 envelope subunit immmunization in humans
Authors: Evans, TG McElrath, MJ Matthews, T Montefiori, D Weinhold, K Wolff, M Keefer, MC Kallas, EG Corey, L Gorse, GJ Belshe, R Graham, BS Spearman, PW Schwartz, D Mulligan, MJ Goepfert, P Fast, P Berman, P Powell, M Francis, D
Citation: Tg. Evans et al., QS-21 promotes an adjuvant effect allowing for reduced antigen dose duringHIV-1 envelope subunit immmunization in humans, VACCINE, 19(15-16), 2001, pp. 2080-2091
Evaluation of canarypox-induced CD8(+) responses following immunization bymeasuring the effector population IFN gamma production
Authors: Evans, TG Kallas, EG Campbell, M Andrews, J Schwartz, D Keefer, M Caudrelier, P
Citation: Tg. Evans et al., Evaluation of canarypox-induced CD8(+) responses following immunization bymeasuring the effector population IFN gamma production, IMMUNOL LET, 77(1), 2001, pp. 7-15
A phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers
Authors: Evans, TG Bonnez, W Rose, RC Koenig, S Demeter, L Suzich, JA O'Brien, D Campbell, M White, WI Balsley, J Reichman, RC
Citation: Tg. Evans et al., A phase 1 study of a recombinant viruslike particle vaccine against human papillomavirus type 11 in healthy adult volunteers, J INFEC DIS, 183(10), 2001, pp. 1485-1493
Effects of interleukin-15 on in vitro human T cell proliferation and activation
Authors: Hasan, MS Kallas, EG Thomas, EK Looney, J Campbell, M Evans, TG
Citation: Ms. Hasan et al., Effects of interleukin-15 on in vitro human T cell proliferation and activation, J INTERF CY, 20(2), 2000, pp. 119-123
Natural history of Leishmania (Leishmania) chagasi infection in northeastern Brazil: Long-term follow-up
Authors: Jeronimo, SMB Teixeira, MJ Sousa, AD Thielking, P Pearson, RD Evans, TG
Citation: Smb. Jeronimo et al., Natural history of Leishmania (Leishmania) chagasi infection in northeastern Brazil: Long-term follow-up, CLIN INF D, 30(3), 2000, pp. 608-609
Low frequency microwave technique for on-line measurement of moisture
Authors: Cutmore, NG Evans, TG McEwan, AJ Rogers, CA Stoddard, SL
Citation: Ng. Cutmore et al., Low frequency microwave technique for on-line measurement of moisture, MINER ENG, 13(14-15), 2000, pp. 1615-1622
The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination
Authors: Evans, TG Schiff, M Graves, B Agosti, J Barritt, ML Garner, D Holley, JL
Citation: Tg. Evans et al., The safety and efficacy of GM-CSF as an adjuvant in hepatitis B vaccination of chronic hemodialysis patients who have failed primary vaccination, CLIN NEPHR, 54(2), 2000, pp. 138-142
Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen
Authors: Valdez, H Smith, KY Landay, A Connick, E Kuritzkes, DR Kessler, H Fox, L Spritzler, J Roe, J Lederman, MB Lederman, HM Evans, TG Heath-Chiozzi, M Lederman, MM
Citation: H. Valdez et al., Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen, AIDS, 14(1), 2000, pp. 11-21
High tech hedging - Measuring the financial impact of derivatives under SFAS 119
Authors: Evans, TG Atkinson, SM Mandal, D
Citation: Tg. Evans et al., High tech hedging - Measuring the financial impact of derivatives under SFAS 119, ADV INT ACC, 13, 2000, pp. 153-171
Production of influenza-stimulated tumor necrosis factor-alpha by monocytes following acute influenza infection in humans
Authors: Kallas, EG Reynolds, K Andrews, J Treanor, JJ Evans, TG
Citation: Eg. Kallas et al., Production of influenza-stimulated tumor necrosis factor-alpha by monocytes following acute influenza infection in humans, J INTERF CY, 19(7), 1999, pp. 751-755
Primary isolate neutralization by HIV type 1-infected patient sera in the era of highly active antiretroviral therapy
Authors: Dreyer, K Kallas, EG Planelles, V Montefiori, D McDermott, MP Hasan, MS Evans, TG
Citation: K. Dreyer et al., Primary isolate neutralization by HIV type 1-infected patient sera in the era of highly active antiretroviral therapy, AIDS RES H, 15(17), 1999, pp. 1563-1571
Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28-and CD8+CD28-T cells in rheumatoid arthritis
Authors: Hooper, M Kallas, EG Coffin, D Campbell, D Evans, TG Looney, RJ
Citation: M. Hooper et al., Cytomegalovirus seropositivity is associated with the expansion of CD4+CD28-and CD8+CD28-T cells in rheumatoid arthritis, J RHEUMATOL, 26(7), 1999, pp. 1452-1457
Demystifying nonparticipation in microcredit: A population-based analysis
Authors: Evans, TG Adams, AM Mohammed, R Norris, AH
Citation: Tg. Evans et al., Demystifying nonparticipation in microcredit: A population-based analysis, WORLD DEV, 27(2), 1999, pp. 419-430
Expansion of the CD57 subset of CD8 T cells in HIV-1 infection is related to CMV serostatus
Authors: Evans, TG Kallas, EG Luque, AE Menegus, M McNair, C Looney, RJ
Citation: Tg. Evans et al., Expansion of the CD57 subset of CD8 T cells in HIV-1 infection is related to CMV serostatus, AIDS, 13(9), 1999, pp. 1139-1141
Global health research and INCLEN
Authors: Macfarlane, SBJ Evans, TG Muli-Musiime, FM Prawl, OL So, AD
Citation: Sbj. Macfarlane et al., Global health research and INCLEN, LANCET, 353(9151), 1999, pp. 503-503
Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination of healthy adults
Authors: Hasan, MS Agosti, JM Reynolds, KK Tanzman, E Treanor, JJ Evans, TG
Citation: Ms. Hasan et al., Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination of healthy adults, J INFEC DIS, 180(6), 1999, pp. 2023-2026
A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with Rgp120 elicits broad and durable CD8(+) cytotoxic T lymphocyte responses in seronegative volunteers
Authors: Evans, TG Keefer, MC Weinhold, KJ Wolff, M Montefiori, D Gorse, GJ Graham, BS McElrath, MJ Clements-Mann, ML Mulligan, MJ Fast, P Walker, MC Excler, JL Duliege, AM Tartaglia, J
Citation: Tg. Evans et al., A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with Rgp120 elicits broad and durable CD8(+) cytotoxic T lymphocyte responses in seronegative volunteers, J INFEC DIS, 180(2), 1999, pp. 290-298
Detection of intracellular antigen-specific cytokines in human T cell populations
Authors: Kallas, EG Gibbons, DC Soucier, H Fitzgerald, T Treanor, JJ Evans, TG
Citation: Eg. Kallas et al., Detection of intracellular antigen-specific cytokines in human T cell populations, J INFEC DIS, 179(5), 1999, pp. 1124-1131
Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers
Authors: Belshe, RB Gorse, GJ Mulligan, MJ Evans, TG Keefer, MC Excler, JL Duliege, AM Tartaglia, J Cox, WI McNamara, J Hwang, KL Bradney, A Montefiori, D Weinhold, KJ
Citation: Rb. Belshe et al., Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers, AIDS, 12(18), 1998, pp. 2407-2415
Cytomegalovirus-specific IFN gamma and IL-4 are produced by antigen expanded human blood lymphocytes from seropositive volunteers
Authors: Kallas, EG Reynolds, K Andrews, J Fitzgerald, T Kasper, M Menegus, M Evans, TG
Citation: Eg. Kallas et al., Cytomegalovirus-specific IFN gamma and IL-4 are produced by antigen expanded human blood lymphocytes from seropositive volunteers, IMMUNOL LET, 64(2-3), 1998, pp. 63-69
Risultati: 1-20 |